Early detection and effective treatments have increased survival rates for women diagnosed with breast cancer (BC),1 with adjuvant endocrine therapy (AET) being an important option for women diagnosed with hormone receptor positive (HR+) BC.2 The gene discussed is NR4A1; the disease is breast cancer.